ZOTEPINE IN THE TREATMENT OF SCHIZOPHRENIC-PATIENTS WITH PREVAILINGLY NEGATIVE SYMPTOMS - A DOUBLE-BLIND TRIAL VS HALOPERIDOL

被引：80
|
作者：
BARNAS, C
STUPPACK, CH
MILLER, C
HARING, C
SPERNERUNTERWEGER, B
FLEISCHHACKER, WW
机构：
[1] Biological Psychiatry Research Unit, Department of Psychiatry, University of Innsbruck
来源：
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY | 1992年 / 7卷 / 01期
关键词：
D O I：
10.1097/00004850-199200710-00003
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Zotepine, a neuroleptic agent with additional 5-HT2 blocking properties, was compared with haloperidol in the treatment of schizophrenic patients with predominantly negative symptoms using a double-blind design. During the investigation period zotepine treated patients showed significant improvements in all rating instruments whereas haloperidol treated patients did not. Patients in the zotepine group developed fewer clinical side effects. The results of the presented study confirm the positive impressions gained in earlier open trials with zotepine.
引用
收藏
页码：23 / 27
页数：5
相关论文
共 50 条
  • [1] ZOTEPINE VS HALOPERIDOL IN ACUTE SCHIZOPHRENIA - A DOUBLE-BLIND TRIAL
    STUPPACK, CH
    BARNAS, C
    UNTERWEGER, B
    MILLER, C
    FLEISCHHACKER, WW
    HINTERHUBER, H
    SCHIZOPHRENIA RESEARCH, 1988, 1 (2-3) : 200 - 201
  • [2] ZOTEPINE VS HALOPERIDOL IN PARANOID SCHIZOPHRENIA - A DOUBLE-BLIND TRIAL
    FLEISCHHACKER, WW
    BARNAS, C
    STUPPACK, CH
    UNTERWEGER, B
    MILLER, C
    HINTERHUBER, H
    PSYCHOPHARMACOLOGY BULLETIN, 1989, 25 (01) : 97 - 100
  • [3] Zotepine versus placebo in the treatment of schizophrenic patients with stable primary negative symptoms:: A randomized double-blind multicenter trial
    Möller, HJ
    Riedel, M
    Müller, N
    Fischer, W
    Kohnen, R
    PHARMACOPSYCHIATRY, 2004, 37 (06) : 270 - 278
  • [4] Efficacy and safety of zotepine for the treatment of Taiwanese schizophrenic patients: A double-blind comparison with haloperidol
    Hwang, TJ
    Lin, SK
    Lin, HN
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2001, 100 (12) : 811 - 816
  • [5] DOUBLE-BLIND COMPARISON BETWEEN LOXAPINE AND HALOPERIDOL IN TREATMENT OF ADOLESCENT SCHIZOPHRENIC-PATIENTS
    VERSIANI, M
    DASILVA, JAR
    FROTA, LH
    MUNDIM, FD
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1978, 24 (05): : 559 - 566
  • [6] THE EFFECT OF ZOTEPINE ON POSITIVE AND NEGATIVE SYMPTOMS IN SCHIZOPHRENIC-PATIENTS
    DIETERLE, DM
    ACKENHEIL, M
    KAPFHAMMER, HP
    KLEIN, HE
    MULLERSPAHN, F
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 1987, 32 (1-2) : 437 - 438
  • [7] RISPERIDONE VERSUS CLOZAPINE IN THE TREATMENT OF SCHIZOPHRENIC-PATIENTS WITH ACUTE SYMPTOMS - A DOUBLE-BLIND, RANDOMIZED TRIAL
    HEINRICH, K
    KLIESER, E
    LEHMANN, E
    KINZLER, E
    HRUSCHKA, H
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1994, 18 (01): : 129 - 137
  • [8] A DOUBLE-BLIND COMPARISON OF BROMPERIDOL AND HALOPERIDOL IN NEWLY ADMITTED SCHIZOPHRENIC-PATIENTS
    BRANNEN, JO
    MCEVOY, JP
    WILSON, WH
    PETRIE, WM
    BAN, TA
    BERNEY, SA
    SCHAFFER, JD
    PHARMACOPSYCHIATRIA, 1981, 14 (04): : 139 - 140
  • [9] DOUBLE-BLIND COMPARATIVE-STUDY OF REMOXIPRIDE AND HALOPERIDOL IN ACUTE SCHIZOPHRENIC-PATIENTS
    DENBOER, JA
    RAVELLI, DP
    HUISMAN, J
    OHRVIK, J
    VERHOEVEN, WMA
    WESTENBERG, HGM
    PSYCHOPHARMACOLOGY, 1990, 102 (01) : 76 - 84
  • [10] A DOUBLE-BLIND CONTROLLED TRIAL OF PIPOTIAZINE, HALOPERIDOL AND PLACEBO IN RECENTLY-HOSPITALIZED ACUTE SCHIZOPHRENIC-PATIENTS
    BECHELLI, LPC
    RUFFINONETTO, A
    HETEM, G
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 1983, 16 (04) : 305 - 311
12345